Key result
Ultrasound-estimated fat fraction accurately diagnosed ≥5% and ≥10% steatosis with AUCs of 0.97 and 0.91 in NAFLD, and 0.99 and 0.96 in MAFLD, compared to MRI-PDFF.
Why the study?
The authors aimed to develop a non-linear regression model based on quantitative ultrasound parameters to predict liver fat fraction similar to MRI-PDFF.
Does an ultrasound-estimated fat fraction model accurately diagnose liver steatosis compared to MRI-PDFF in patients with NAFLD and MAFLD?
Cross-Sectional (n=141)
Does an ultrasound-estimated fat fraction model accurately diagnose liver steatosis compared to MRI-PDFF in patients with NAFLD and MAFLD?
An ultrasound-estimated fat fraction model using quantitative ultrasound parameters provides high diagnostic accuracy for liver steatosis compared to MRI-PDFF in NAFLD and MAFLD patients.
Answers are grounded in this paper and cite their sources.
QUS model may aid noninvasive liver fat estimation; leaves open prospective validation against MRI-PDFF before clinical adoption.
We aimed to develop a non-linear regression model that could predict the fat fraction of the liver (USFF), similar to magnetic resonance imaging proton density fat fraction (MRI-PDFF), based on quantitative ultrasound (QUS) parameters. We measured and retrospectively collected the ultrasound attenuation coefficient (AC), backscatter-distribution coefficient (BSC-D), and liver stiffness (LS) using shear wave elastography (SWE) in 90 patients with clinically suspected non-alcoholic fatty liver disease (NAFLD) and 51 patients with clinically suspected metabolic-associated fatty liver disease (MAFLD). The MRI-PDFF was also measured in all patients within a month of the ultrasound scan. In the linear regression analysis, only AC and BSC-D showed a significant association with MRI-PDFF. Therefore, we developed prediction models using non-linear least-squares analysis to estimate MRI-PDFF based on the AC and BSC-D parameters. We fitted the models on the NAFLD dataset and evaluated their performance in 3-fold cross-validation repeated five times. We decided to use the model based on both parameters to estimate the ultrasound fat fraction (USFF). The correlation between USFF and MRI-PDFF was strong in NAFLD and very strong in MAFLD. According to a receiver operating characteristics (ROC) analysis, USFF could differentiate between <5% vs. ≥ 5% and < 10% vs. ≥ 10% MRI-PDFF steatosis with excellent, 0.97 and 0.91 area under the curve (AUC) accuracy in the NAFLD and with AUCs of 0.99 and 0.96 in the MAFLD groups. In conclusion, USFF calculated from QUS parameters is an accurate method to quantify liver fat fraction and to diagnose ≥ 5% and ≥ 10% steatosis in both NAFLD and MAFLD. Therefore, USFF can be an ideal non-invasive screening tool for patients with NAFLD and MAFLD risk factors.
No takes yet. Share an insight, caveat, or question.
Kaposi et al. (2023) conducted a cross-sectional in Non-alcoholic fatty liver disease (NAFLD) and metabolic-associated fatty liver disease (MAFLD) (n=141). Ultrasound-estimated fat fraction (USFF) vs. Magnetic resonance imaging proton density fat fraction (MRI-PDFF) was evaluated on Differentiation between <5% vs. ≥5% and <10% vs. ≥10% MRI-PDFF steatosis (AUC 0.97 and 0.91 (NAFLD); AUC 0.99 and 0.96 (MAFLD)). Ultrasound-estimated fat fraction accurately diagnosed ≥5% and ≥10% steatosis with AUCs of 0.97 and 0.91 in NAFLD, and 0.99 and 0.96 in MAFLD, compared to MRI-PDFF.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: